Primary |
Anxiety |
40.6% |
Depression |
13.7% |
Panic Disorder |
8.6% |
Panic Attack |
7.6% |
Nervous System Disorder |
5.1% |
Hypertension |
3.6% |
Generalised Anxiety Disorder |
3.0% |
Blood Cholesterol Increased |
2.5% |
Nervousness |
2.0% |
Post-traumatic Stress Disorder |
2.0% |
Bipolar Disorder |
1.5% |
Diabetes Mellitus |
1.5% |
Gastrointestinal Disorder |
1.5% |
Agoraphobia |
1.0% |
Blood Pressure High |
1.0% |
Ex-smoker |
1.0% |
Insomnia |
1.0% |
Major Depression |
1.0% |
Pain |
1.0% |
Affective Disorder |
0.5% |
|
Drug Ineffective |
15.0% |
Tremor |
10.0% |
Panic Attack |
7.5% |
Death |
6.3% |
Malaise |
6.3% |
Weight Decreased |
6.3% |
Fatigue |
5.0% |
Hypersensitivity |
5.0% |
Somnolence |
5.0% |
Withdrawal Syndrome |
5.0% |
Drug Effect Decreased |
3.8% |
Insomnia |
3.8% |
Premature Baby |
3.8% |
Breast Cancer |
2.5% |
Drug Dependence |
2.5% |
Drug Intolerance |
2.5% |
Drug Withdrawal Syndrome |
2.5% |
Gastric Disorder |
2.5% |
Gastrooesophageal Reflux Disease |
2.5% |
Influenza |
2.5% |
|
Secondary |
Anxiety |
29.6% |
Depression |
18.5% |
Panic Attack |
10.9% |
Panic Disorder |
9.7% |
Hypertension |
3.8% |
Blood Cholesterol Increased |
3.2% |
Generalised Anxiety Disorder |
3.2% |
Nervousness |
3.2% |
Nervous System Disorder |
2.9% |
Bipolar Disorder |
2.3% |
Anxiety Disorder |
1.8% |
Gastrointestinal Disorder |
1.8% |
Product Used For Unknown Indication |
1.5% |
Sleep Disorder |
1.5% |
Attention Deficit/hyperactivity Disorder |
1.2% |
Blood Pressure High |
1.2% |
Post-traumatic Stress Disorder |
1.2% |
Stress |
1.2% |
Insomnia |
0.9% |
Agoraphobia |
0.6% |
|
Malaise |
11.9% |
Withdrawal Syndrome |
11.9% |
Tremor |
9.0% |
Panic Attack |
7.5% |
Somnolence |
7.5% |
Anxiety |
4.5% |
Depression |
4.5% |
Drug Intolerance |
4.5% |
Mental Disorder |
4.5% |
Weight Decreased |
4.5% |
Abdominal Discomfort |
3.0% |
Activities Of Daily Living Impaired |
3.0% |
Blood Cholesterol Increased |
3.0% |
Drug Dependence |
3.0% |
Drug Effect Decreased |
3.0% |
Drug Ineffective |
3.0% |
Drug Ineffective For Unapproved Indication |
3.0% |
Fatigue |
3.0% |
Feeling Abnormal |
3.0% |
Hyperhidrosis |
3.0% |
|
Concomitant |
Product Used For Unknown Indication |
29.5% |
Anxiety |
10.0% |
Depression |
6.8% |
Crohn's Disease |
5.6% |
Drug Exposure During Pregnancy |
5.3% |
Gastrooesophageal Reflux Disease |
4.9% |
Insomnia |
4.0% |
Sleep Disorder |
4.0% |
Pain |
3.8% |
Panic Attack |
3.5% |
Drug Use For Unknown Indication |
3.0% |
Hypertension |
2.8% |
Rheumatoid Arthritis |
2.8% |
Migraine |
2.6% |
Bipolar Disorder |
2.5% |
Hypersensitivity |
2.5% |
Asthma |
1.8% |
Chronic Obstructive Pulmonary Disease |
1.8% |
Blood Cholesterol Increased |
1.5% |
Convulsion |
1.5% |
|
Weight Increased |
12.3% |
Type 2 Diabetes Mellitus |
9.6% |
Vomiting |
9.6% |
Oedema Peripheral |
5.5% |
Pulmonary Embolism |
5.5% |
Suicidal Ideation |
5.5% |
Tremor |
5.5% |
Nausea |
4.1% |
Pain In Extremity |
4.1% |
Pancreatitis |
4.1% |
Product Quality Issue |
4.1% |
Urinary Tract Infection |
4.1% |
Ventricular Fibrillation |
4.1% |
Ventricular Septal Defect |
4.1% |
Weight Decreased |
4.1% |
Completed Suicide |
2.7% |
Conversion Disorder |
2.7% |
Depression |
2.7% |
Drug Ineffective |
2.7% |
Dyspnoea |
2.7% |
|
Interacting |
Staphylococcal Infection |
66.7% |
Panic Disorder |
33.3% |
|
Staphylococcal Infection |
100.0% |
|